Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18658109 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Condition: Complication of Transplanted Lung
Interventions: Drug: Aztreonam Lysine for Inhalation (AZLI);   Procedure: Status Post Lung Transplant
2 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID);   Drug: Placebo two times a day (BID)/three times a day (TID)

Indicates status has not been verified in more than two years